-->

Company Registry

  1. You are here:    Home
  2. Pacific Diabetes Technologies

Pacific Diabetes Technologies (AKA:PDT)
Profile last edited on: 2/4/2020

Integrated artificial pancreas
Year Founded
2011
First SBIR Year
2013
Latest SBIR Award
2021
Program Status
Active

WikiProfile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation

Location Information

2828 SW Corbett Avenue Suite 211-A
Portland, OR 97201
   (503) 847-9170
   info@pacificdt.com
   pacificdt.com
Multiple Locations:   
Congressional District:   03
County:   Multnomah

Public Profile

Pacific Diabetes Technologies ("PDT") is dedicated to the goal of creating an accessible integrated artificial pancreas. Combining the artificial pancreas and sensor chemistry knowledge of PDT team with the microelectronic fabrication expertise of Professors Greg Herman and John Conley of Oregon State University, PDT is well situated to develop devices that are needed for a reliable artificial pancreas to market. These devices will help make life simpler for people with Type 1 diabetes or insulin-treated Type 2 diabetes.

Extent of SBIR involvement

User Avatar
3
Phase I Awards
1
Phase II Awards
33.33%
Conversion Rate
$746,440
Phase I Dollars
$945,509
Phase II Dollars
$1,691,949
Total Awarded

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
---
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount Project Title
2021 2 NIH $1,245,064
Development of a Miniaturized, Single-Port Automated Insulin Delivery System Utilizing a Glucose Sensing Catheter, Ultra-Concentrated Insulin, and an Optimized Control Algorithm
1 NIH $224,150
Avoidance of Interference from Insulin Preservatives in a Dual-use Catheter for T1D
1 NIH $222,735
Development of a Wearable Telemetry Module and Dual Hormone Infusion Set for Use

Key People / Management

  Robert S Cargill -- President and CEO

  Jessica R Castle --

  W Kenneth Ward -- Chief Science Officer

SBIR firms in the news

There are no news available.